The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Immatics competitive analysis

Loading summary...

Latest patents of Immatics opposed by its competitors

Explore Immatics's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 13, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP3980776
Aug 28, 2024Sorting With Counter Selection Using Sequence Similar Peptides1
EP3236985
Sep 7, 2022Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Hepatocellular Carcinoma (Hcc) And Other Cancers1

Latest PTAB cases involving Immatics

Discover the latest PTAB cases involving Immatics, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Immatics with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
IMMATICS BIOTECHNOLOGIES - 2 - -
ADAPTIMMUNE110 - -
STRAWMAN339 - - -